TCL Archive In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs November 27, 1998
TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
TCL Archive HHS lawyer tells of pressure to allow former NCI Director Richard Klausner to receive $40,000 prize. May 21, 2004
